Diabetes is life long affliction that causes a person’s blood sugar level to become too high. With the two main types of diabetes, type 2 is far more common. Around 90% of all adults with diabetes have type 2.
Types
Type 2 is where the body is not creating enough insulin or the body is not reacting correctly to the insulin. This type usually requires the managing of medication, finding the right medication for each person can take time. Also many of the medications have side affects.
Type 1 is when the level of glucose in blood to be too high. This happens when the body isn’t producing enough of the hormone insulin which controls the levels of glucose in blood.
Both types are manageable with the correct advice and medication.
There are articles below that explore the condition in many different ways. Covering new research and evidence.
Afon Technology is a leader in advanced medical technology focused on transforming diabetes care. Brad Love and Dan Fowles discuss how the company uses big data to create personalised health solutions that can significantly impact the lives of millions.
Hilde Bastiaens, Principal Investigator and Project Coordinator, and Geofrey Musinguzi, Project Manager of Horizon 2020 funded SPICES reveal why engaging with communities is important in preventing cardiovascular disease.
The University of Manchester finds that Flash technology is better than finger-prick testing, keeping diabetes patients at a good blood sugar level - for an extra two hours per day.
A study finds that parents are less likely to buy sugary drinks when they have warnings about health on their labels – reducing sugary drink purchases by 17%.
Researchers find that ethnic minority diabetes patients are less likely to take medication for their treatment, due to income differences and lack of access.
Scientists have created an 'artificial pancreas' that uses an algorithm to protect the body - especially ground-breaking for young children with type 1 diabetes.
Claire Kendal-Wright, PhD, from Chaminade University of Honolulu, argues that when it comes to understanding the normal human parturition mechanisms, danger associated molecular patterns may be part of the answer.
